相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial
Vivek Shinde et al.
LANCET INFECTIOUS DISEASES (2022)
Structure Elucidation of Triterpenoid Saponins Found in an Immunoadjuvant Preparation of Quillaja brasiliensis Using Mass Spectrometry and 1H and 13C NMR Spectroscopy
Federico Wallace et al.
MOLECULES (2022)
ISCOM-Matrices Nanoformulation Using the Raw Aqueous Extract of Quillaja lancifolia (Q. brasiliensis)
Samuel Cibulski et al.
BIONANOSCIENCE (2022)
IMXQB-80: A Quillaja brasiliensis saponin-based nanoadjuvant enhances Zika virus specific immune responses in mice
Samuel Cibulski et al.
VACCINE (2021)
Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and Splenocyte Proliferation
Samuel Cibulski et al.
FRONTIERS IN IMMUNOLOGY (2021)
Multiple Levels of Immunological Memory and Their Association with Vaccination
Zsofia Bugya et al.
VACCINES (2021)
Emerging concepts in the science of vaccine adjuvants
Bali Pulendran et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review
Marie-Aleth Lacaille-Dubois
PHYTOMEDICINE (2019)
Foamy matters: an update on Quillaja saponins and their use as immunoadjuvants
Yve V. S. Magedans et al.
FUTURE MEDICINAL CHEMISTRY (2019)
ZIKV infection induces robust Th1-like Tfh cell and long-term protective antibody responses in immunocompetent mice
Huabin Liang et al.
NATURE COMMUNICATIONS (2019)
Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants
Dante J. Marciani
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines
Samuel Cibulski et al.
VACCINE (2018)
Adjuvanted influenza vaccines
John S. Tregoning et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
Arnaud M. Didierlaurent et al.
EXPERT REVIEW OF VACCINES (2017)
Analysis of an immunoadjuvant saponin fraction from Quillaja brasiliensis leaves by electrospray ionization ion trap multiple-stage mass spectrometry
Federico Wallace et al.
PHYTOCHEMISTRY LETTERS (2017)
Quillaja brasiliensis saponins induce robust humoral and cellular responses in a bovine viral diarrhea virus vaccine in mice
Samuel Paulo Cibulski et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2016)
Protective neutralizing influenza antibody response in the absence of T follicular helper cells
Kosuke Miyauchi et al.
NATURE IMMUNOLOGY (2016)
Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake
Samuel Paulo Cibulski et al.
VACCINE (2016)
Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability
Emilia Bigaeva et al.
PLOS ONE (2016)
A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets
Mariana Baz et al.
JOURNAL OF VIROLOGY (2015)
Nonreplicating Influenza A Virus Vaccines Confer Broad Protection against Lethal Challenge
Mariana Baz et al.
MBIO (2015)
A Live Attenuated Equine H3N8 Influenza Vaccine Is Highly Immunogenic and Efficacious in Mice and Ferrets
Mariana Baz et al.
JOURNAL OF VIROLOGY (2015)
Small Wonders-The Use of Nanoparticles for Delivering Antigen
Aya Taki et al.
VACCINES (2015)
Combatting infectious diseases; nanotechnology as a platform for rational vaccine design
Elly van Riet et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Broadly neutralizing antibodies against influenza viruses
Nick S. Laursen et al.
ANTIVIRAL RESEARCH (2013)
High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009-2010 season
Carlos A. DiazGranados et al.
VACCINE (2013)
ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway
Nicholas S. Wilson et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Adjuvanted influenza vaccines
Nicola Principi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Alum-type Adjuvant Effect of Non-haemolytic Saponins Purified from Ilex and Passiflora spp.
F. Silveira et al.
PHYTOTHERAPY RESEARCH (2011)
Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation
F. Silveira et al.
VACCINE (2011)
ISCOMATRIX (TM) vaccines Safety in human clinical studies
Andrew McKenzie et al.
HUMAN VACCINES (2010)
Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins
DJ Marciani et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
分享论文
